Health
Multi-center Phase I study of anti-VISTA opens for patient enrollment – News-Medical.Net
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, no…
Reviewed by Emily Henderson, B.Sc.Oct 7 2020
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, now open and recruiting for patient enrollment. The trial is a Phase I study of CI-8993, an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody, in adult patients with advanced solid tumors.
VISTA is a checkpoint regulator whose function is to prevent activation of the immu…
-
General14 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News23 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Business24 hours agoBuying ASX shares? Here’s what to know before the RBA starts hiking interest rates
-
Noosa News23 hours agoHow to get $80,000 grants after severe hail